Item 184
approved contractSep 25, 2024
Description
Authorize the Division of Risk and Benefits to exercise their option to extend the existing contract with Milliman, Inc., Seattle, WA (originally approved by G&C on 2/3/21, Item #41), in the approximate amount of $275,500, increasing the total amount of the contract with $510,100 to an amount not to exceed $785,600 and extending the completion date from December 31, 2024 to December 31, 2026 for Pharmacy Benefit Manager Technology Services pursuant to RSA 21-I:98, the New Hampshire Prescription Drug Competitive Marketplace. Effective upon G&C approval. Approximately 35% General Funds, 17% Federal Funds, 3% Enterprise Funds, 10% Highway Funds, 1% Turnpike Funds, 34% Other Funds
Amount
$785,600
$275,500,, $510,100, $785,600
Department
DEPARTMENT OF ADMINISTRATIVE SERVICES
Funding Source
35% General Funds; 17% Federal Funds; 3% Enterprise Funds; 10% Highway Funds; 1% Turnpike Funds; 34% Other Funds
Effective Dates
December 31, 2024 — December 31, 2026
Vote Record
approved
Motion by Kenney, seconded by Wheeler acted as follows
Joseph Kenney
(R)
yes
Cinde Warmington
(D)
yes
Janet Stevens
(R)
yes
Ted Gatsas
(R)
yes
Dave Wheeler
(R)
yes
Documents (1)
Item_184.pdf
Open in new tab →